Aureon Laboratories focused on developing the advancement of predictive and personalized cancer treatment options. Founded by Jon Edelson in 2001, Aureon Laboratories is backed by investors that include Atlas Venture, New Leaf Venture Partners, Pfizer, Pfizer Venture Investments, and Sprout Group and is headquartered in New York.